Metaage Stock

Metaage Equity

The The Equity of Metaage (6112.TW) as of Aug 8, 2026 is 4.31 B TWD. In the previous year, The Equity was 4.07 B TWD — a change of 5.72% (higher).

Equity

4.31 BTWD

YoY

5.72%

Last updated:

In 2026, Metaage's equity was 4.31 B TWD, a 5.72% increase from the 4.07 B TWD equity in the previous year.

Access this data via the Eulerpool API

Metaage Stock analysis

What does Metaage do? The Metaage Corp is an innovative company based in San Francisco that specializes in the development of technologies for cognitive aging research. The company was founded in 2016 by a team of experts from various fields, such as science, medicine, and technology. The idea for the founding of Metaage Corp arose from the growing awareness of the impact of demographic change on society. The company aims to develop technologies that help older people maintain their cognitive health and make aging a positive experience. The business model of Metaage Corp is based on a broad research and development strategy that includes the development of new products and technologies for use in various fields. The company is divided into several divisions, including the division for medical devices, the division for software applications, and the division for data analysis. The medical devices of Metaage Corp are aimed at the health and well-being of older people. This includes a wide range of products, such as smart pillows that improve sleep and reduce the risk of falls, as well as wearable devices that enable continuous monitoring of health parameters, such as blood pressure and heart rate. The software applications of Metaage Corp are aimed at improving the cognitive abilities of older people. This includes a range of games and exercises that activate the brain and increase cognitive performance in a playful way. The data analysis department of Metaage Corp specializes in the collection and analysis of medical and health-related data. The company works closely with medical institutions and researchers to understand and analyze the effects of aging and age-related diseases on cognitive health. The offering of Metaage Corp is complemented by a series of training sessions and courses aimed at medical professionals, researchers, and health organizations. The training aims to deepen understanding of the latest developments in aging research and contribute to the development of appropriate treatment options and therapies. Metaage Corp has become a key player in aging research and is supported by numerous researchers and medical professionals. The company aims to meet the challenges of demographic change with innovative and advanced technologies and products and contribute to making the lives of older people more positive. Metaage is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Metaage's Equity

Metaage's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Metaage's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Metaage's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Metaage's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Metaage’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Metaage stock

The Equity of Metaage is 4.31 B TWD in 2026.

The Equity of Metaage changed from 4.07 B TWD to 4.31 B TWD, representing a 5.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Metaage since 2006 – with annual values, charts, and detailed analysis.

The Equity's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Metaage historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Metaage

All Key Metrics — Metaage